Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating ASC41 tablets for safety, tolerability, and efficacy in adults with nonalcoholic fatty liver disease and nonalcoholic steatohepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• ASC41 Tablets

Snippet

Sponsor: Gannex Pharma Co., Ltd. | Conditions: Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING